Author

S. A. Burnap

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:protein structure· 1 Assay:proteomics· 1

Frequent Co-Authors

W. B. Struwe· 2 shared A. J. Baldwin· 1 shared A. Olerinyova· 1 shared A. Turner· 1 shared B. G. Davis· 1 shared C. J. Buchanan· 1 shared C. M. Kobras· 1 shared D. I. Stuart· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

W. B. Struwe

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Haptenic adducts of beta-lactam antibiotics elicit antibody responses with narrow clonality and specificity

L. P. Deimel, L. Moynie, G. Sun, V. Lewis, A. Turner, C. J. Buchanan, S. A. Burnap, C. M. Kobras, M. Stracy, W. B. Struwe, A. J. Baldwin, J. Naismith, B. G. Davis, Q. J. Sattentau

This study investigates how penicillin G forms immunogenic adducts on proteins and elicits specific antibody responses in mice, revealing clonal dominance and limited cross-reactivity with other beta-lactam antibiotics.

bioRxiv · Nov 2, 2023 · PreprintImmunology

Cooperativity and induced oligomerisation control the interaction of SARS- CoV-2 with its cellular receptor and patient-derived antibodies

R. Asor, A. Olerinyova, S. A. Burnap, M. S. Kushwah, F. Soltermann, L. P. Rudden, M. Hensen, S. Vasiljevic, J. Brun, M. Hill, L. Chang, W. Dejnirattisai, P. Supasa, J. Mongkolsapaya, D. Zhou, , P. Kukura

The paper investigates how multivalent interactions between SARS-CoV-2 spike protein, ACE2 receptor, and patient-derived antibodies influence viral entry and antibody inhibition.

bioRxiv · Sep 14, 2023 · PreprintBiophysics